March 25, 2013

Health Canada Decision Appealed

Theratechnologies Inc. (TSX : TH) today announced that it has filed with Health Canada a request for reconsideration of its Notice of Non-compliance-Withdrawal (NON/w) for its New Drug Submission (NDS) for tesamorelin proposed for the treatment of excess abdominal fat in HIV-infected patients with lipodystrophy.